JOSÉ SALDANHA

Person

ENFIELD, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 11,345,749
- Issue date May 31, 2022
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 10,875,909
- Issue date Dec 29, 2020
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 10,723,792
- Issue date Jul 28, 2020
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 10,597,441
- Issue date Mar 24, 2020
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 10,450,369
- Issue date Oct 22, 2019
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to VLA-1
- Patent number 10,336,826
- Issue date Jul 2, 2019
- Biogen MA Inc.
- Michael Karpusas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 10,118,960
- Issue date Nov 6, 2018
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 9,884,906
- Issue date Feb 6, 2018
- Prothena Biosciences Limited
- Jose William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 9,670,273
- Issue date Jun 6, 2017
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to VLA-1
- Patent number 9,644,030
- Issue date May 9, 2017
- Biogen MA Inc.
- Michael Karpusas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 9,556,259
- Issue date Jan 31, 2017
- Prothena Biosciences Limited
- José William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 9,234,031
- Issue date Jan 12, 2016
- Prothena Biosciences Limited
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 9,217,030
- Issue date Dec 22, 2015
- Prothena Biosciences Limited
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti ganglioside GD3 antibodies and uses thereof
- Patent number 9,205,157
- Issue date Dec 8, 2015
- Sloan-Kettering Institute for Cancer Research
- Paul Chapman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize beta amyloid peptide
- Patent number 9,051,363
- Issue date Jun 9, 2015
- JANSSEN SCIENCES IRELAND UC
- Guriq Basi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ανβ6 antibodies and uses thereof
- Patent number 8,992,924
- Issue date Mar 31, 2015
- Biogen Idec MA Inc.
- Shelia M. Violette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment and prophylaxis of amyloidosis
- Patent number 8,791,243
- Issue date Jul 29, 2014
- Onclave Therapeutics Limited
- Dale B. Schenk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 8,790,644
- Issue date Jul 29, 2014
- Neotope Biosciences Limited
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize alpha-synuclein
- Patent number 8,609,820
- Issue date Dec 17, 2013
- Neotope Biosciences Limited
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies against monocyte chemotactic proteins
- Patent number 8,519,112
- Issue date Aug 27, 2013
- Biogen Idec MA Inc.
- Antonin R. De Fougerolles
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-amyloid antibodies
- Patent number 8,268,973
- Issue date Sep 18, 2012
- Onclave Therapeutics
- Dale B. Schenk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting alpha-4-dependent interactions with VCAM-1 wi...
- Patent number 8,246,958
- Issue date Aug 21, 2012
- Elan Pharmaceuticals, Inc.
- Mary M. Bendig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against human interleukin-13 and uses therefor
- Patent number 8,221,752
- Issue date Jul 17, 2012
- Wyeth LLC
- Marion T. Kasaian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti ganglioside GD3 antibodies and uses thereof
- Patent number 8,207,308
- Issue date Jun 26, 2012
- Sloan-Kettering Institute for Cancer Research
- Paul Chapman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies that recognize beta amyloid peptide
- Patent number 8,128,928
- Issue date Mar 6, 2012
- Wyeth LLC
- Guriq Basi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to VLA-1
- Patent number 8,084,028
- Issue date Dec 27, 2011
- Biogen Idec MA Inc.
- Michael Karpusas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cripto binding molecules
- Patent number 8,021,661
- Issue date Sep 20, 2011
- Biogen Idec MA Inc.
- Scott Glaser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-αvβ6 antibodies and uses thereof
- Patent number 7,943,742
- Issue date May 17, 2011
- Biogen Idec MA Inc.
- Shelia M. Violette
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric, humanized, or human antibody 2A4
- Patent number 7,928,203
- Issue date Apr 19, 2011
- Elan Pharmaceuticals, Inc.
- Dale B. Schenk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to VLA-1
- Patent number 7,910,099
- Issue date Mar 22, 2011
- Biogen Idec MA Inc.
- Michael Karpusas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20220411486
- Publication date Dec 29, 2022
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- G01 - MEASURING TESTING
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20210040188
- Publication date Feb 11, 2021
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- G01 - MEASURING TESTING
Information Patent Application
Treatment and Prophylaxis of Amyloidosis
- Publication number 20210008185
- Publication date Jan 14, 2021
- University of Tennessee Research Foundation
- Dale B. SCHENK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20200277362
- Publication date Sep 3, 2020
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20200024336
- Publication date Jan 23, 2020
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20190153080
- Publication date May 23, 2019
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20180360934
- Publication date Dec 20, 2018
- PROTHENA THERAPEUTICS LIMITED
- DALE B. SCHENK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20180201669
- Publication date Jul 19, 2018
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20180016329
- Publication date Jan 18, 2018
- PROTHENA BIOSCIENCES LIMITED
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO VLA-1
- Publication number 20170335000
- Publication date Nov 23, 2017
- Biogen MA Inc.
- Michael Karpusas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20170240621
- Publication date Aug 24, 2017
- PROTHENA BIOSCIENCES LIMITED
- Jose William Saldanha
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20170081396
- Publication date Mar 23, 2017
- PROTHENA THERAPEUTICS LIMITED
- DALE B. SCHENK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20160251416
- Publication date Sep 1, 2016
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO VLA-1
- Publication number 20150299323
- Publication date Oct 22, 2015
- Biogen MA Inc.
- Michael Karpusas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20150158937
- Publication date Jun 11, 2015
- ONCLAVE THERAPEUTICS LIMITED
- Dale B. SCHENK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC USES OF HUMANIZED ANTIBODIES AGAINST ALPHA-4 INTEGRIN
- Publication number 20150064177
- Publication date Mar 5, 2015
- Biogen Idec MA Inc.
- Mary M. BENDIG
- G01 - MEASURING TESTING
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20150056187
- Publication date Feb 26, 2015
- Neotope Biosciences Limited
- Jose Saldanha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20150024433
- Publication date Jan 22, 2015
- Neotope Biosciences Limited
- Jose Saldanha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-Alpha(v)Beta(6) Antibodies and Uses Thereof
- Publication number 20140294809
- Publication date Oct 2, 2014
- Biogen Idec MA Inc.
- Shelia M. Violette
- G01 - MEASURING TESTING
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20140275495
- Publication date Sep 18, 2014
- Neotope Biosciences Limited
- José William Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20140134103
- Publication date May 15, 2014
- University of Tennessee Research Foundation
- Dale B. SCHENK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS
- Publication number 20140079697
- Publication date Mar 20, 2014
- Biogen Idec MA Inc.
- Antonin R. DE FOUGEROLLES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20130266517
- Publication date Oct 10, 2013
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies That Recognize Alpha-Synuclein
- Publication number 20130108546
- Publication date May 2, 2013
- Neotope Biosciences Limited
- Jose Saldanha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin
- Publication number 20130059337
- Publication date Mar 7, 2013
- Elan Pharmaceuticals, Inc.
- Mary M. Bendig
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20120321555
- Publication date Dec 20, 2012
- University of Tennessee Research Foundation
- Dale B. SCHENK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI GANGLIOSIDE GD3 ANTIBODIES AND USES THEREOF
- Publication number 20120276046
- Publication date Nov 1, 2012
- Sloan-Kettering Institute for Cancer Research
- Paul Chapman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20120189624
- Publication date Jul 26, 2012
- Elan Pharmaceuticals, Inc.
- Dale B. Schenk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO VLA-1
- Publication number 20120177638
- Publication date Jul 12, 2012
- Biogen Idec MA Inc.
- Michael Karpusas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
- Publication number 20120039878
- Publication date Feb 16, 2012
- Elan Pharmaceuticals, Inc.
- Dale B. Schenk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

JOSÉ SALDANHA

Person

Patents Grantslast 30 patents

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Antibodies to VLA-1

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Antibodies to VLA-1

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Anti ganglioside GD3 antibodies and uses thereof

Humanized antibodies that recognize beta amyloid peptide

Anti-ανβ6 antibodies and uses thereof

Treatment and prophylaxis of amyloidosis

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies that recognize alpha-synuclein

Humanized antibodies against monocyte chemotactic proteins

Anti-amyloid antibodies

Methods of inhibiting alpha-4-dependent interactions with VCAM-1 wi...

Antibodies against human interleukin-13 and uses therefor

Anti ganglioside GD3 antibodies and uses thereof

Humanized antibodies that recognize beta amyloid peptide

Antibodies to VLA-1

Cripto binding molecules

Anti-αvβ6 antibodies and uses thereof

Chimeric, humanized, or human antibody 2A4

Antibodies to VLA-1

Patents Applicationslast 30 patents

Humanized Antibodies That Recognize Alpha-Synuclein

Humanized Antibodies That Recognize Alpha-Synuclein

Treatment and Prophylaxis of Amyloidosis

Humanized Antibodies That Recognize Alpha-Synuclein

Humanized Antibodies That Recognize Alpha-Synuclein

Humanized Antibodies That Recognize Alpha-Synuclein

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

Humanized Antibodies That Recognize Alpha-Synuclein

Humanized Antibodies That Recognize Alpha-Synuclein

ANTIBODIES TO VLA-1

Humanized Antibodies That Recognize Alpha-Synuclein

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

Humanized Antibodies That Recognize Alpha-Synuclein

ANTIBODIES TO VLA-1

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

THERAPEUTIC USES OF HUMANIZED ANTIBODIES AGAINST ALPHA-4 INTEGRIN

Humanized Antibodies That Recognize Alpha-Synuclein

Humanized Antibodies That Recognize Alpha-Synuclein

Anti-Alpha(v)Beta(6) Antibodies and Uses Thereof

Humanized Antibodies That Recognize Alpha-Synuclein

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

HUMANIZED ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS

Humanized Antibodies That Recognize Alpha-Synuclein

Humanized Antibodies That Recognize Alpha-Synuclein

Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

ANTI GANGLIOSIDE GD3 ANTIBODIES AND USES THEREOF

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS

ANTIBODIES TO VLA-1

TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS